Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.00
-1.41 (-7.69%)
Jun 5, 2026, 3:56 PM EDT - Market open
Dyne Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $18 → $47 | Buy | Reiterates | $18 → $47 | +176.55% | May 26, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +158.90% | May 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +194.20% | May 21, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $40 | Buy | Reiterates | $40 | +135.36% | May 21, 2026 |
| Evercore ISI | Evercore ISI | Buy Reiterates $34 → $33 | Buy | Reiterates | $34 → $33 | +94.17% | May 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $45 | Buy | Reiterates | $45 | +164.78% | May 14, 2026 |
| Bernstein | Bernstein | Hold Reiterates $23 → $24 | Hold | Reiterates | $23 → $24 | +41.22% | May 13, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $30 | Buy | Reiterates | $30 | +76.52% | May 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.